Short answer

HPV vaccination is cancer prevention in a syringe: Gardasil 9 blocks the nine HPV types behind most cervical, anal, throat, vaginal, vulvar, and penile cancers plus genital warts.

Best given before exposure (routine at 11–12), still valuable after (catch-up through 26, discussed to 45). Prior infection never blocks benefit against uncovered types.

Vaccination prevents future infections; it treats nothing existing and replaces no screening.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Schedule. Doses by starting age

  • Two doses 6–12 months apart when the series starts before age 15 (younger immune systems responding strongly to fewer doses).
  • Three doses when starting at 15+, when immunocompromised, or per catch-up protocols.
  • Routine at 11–12, permitted from age 9 (pre-exposure timing maximizing benefit).
  • Catch-up through 26 routinely; ages 27–45 after shared decision-making with a clinician (especially valuable with new partners. Exposure futures, not pasts, drive the decision).

Confirm current CDC dosing intervals at the visit. Schedules evolve.

Adult-men specifics at HPV Vaccination for Adult Men.

Effectiveness. Population proof at scale

  • Steep drops in vaccine-type infections, genital warts, and precancers where uptake is high (measured across countries within years of program starts).
  • Protection lasting (no booster currently recommended. Durability measured in decades and continuing).
  • Coverage of the types behind roughly 90% of HPV cancers (nine types. The highest-yield cancer prevention per dose in medicine).

Effectiveness is highest pre-exposure and remains meaningful post-exposure (uncovered types still prevented. Prior infection with one type never implies exposure to all nine).

Safety record. Monitored at unprecedented scale

  • Hundreds of millions of doses worldwide over 15+ years with continuous safety surveillance.
  • Typical effects: injection-site soreness, brief dizziness or faintness (sit 15 minutes post-shot. Common to all teen vaccines).
  • No confirmed serious safety signals across large studies (no link to infertility, autoimmune surge, or adverse reproductive patterns. The fertility fears are misinformation; preventing precancer treatment is what actually protects fertility).

Safety data rank among the strongest of any vaccine in use.

What it doesn’t do. Stated plainly

  • Doesn’t treat existing infections, warts, or abnormal Pap results (therapeutic vaccines remain investigational. Current vaccines are purely preventive).
  • Doesn’t cover every HPV type (nine of 200+. The oncogenic minority causing most disease).
  • Doesn’t replace cervical screening (vaccinated people follow identical screening schedules. Pre-vaccination exposures and uncovered types persist).

When to seek care

Ask about vaccination at any visit through the eligible ages, before college or new relationships, and during pregnancy planning (vaccination is deferred during pregnancy itself. Discuss timing).